Concepedia

Bradley Whitener

BW

Statistics

Publications

20

Citations

2K

H-Index

18

Active since

2021

Affiliations

Washington University in St. Louis(Current)

Moderna Therapeutics (United States)

National Institute of Allergy and Infectious Diseases

Vanderbilt University Medical Center

National Institutes of Health

Bradley Whitener is an author at Washington University in St. Louis specializing in infectious diseases, immunology, and vaccinology.

ORCID

Publications per year

2021–2024

20

Publications

20

SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters

Peter Halfmann, Shun Iida, Kiyoko Iwatsuki‐Horimoto et al. · Nature · 2022 · 698 citations · Full text

, , +14

Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice

Suzanne M. Scheaffer, Diana Lee, Bradley Whitener et al. · Nature Medicine · 2022 · 182 citations · Full text

, , +11

Neutralization, effector function and immune imprinting of Omicron variants

Amin Addetia, Luca Piccoli, James Brett Case et al. · Nature · 2023 · 181 citations · Full text

, , +14

Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains

James Brett Case, Samantha Mackin, John M. Errico et al. · Nature Communications · 2022 · 154 citations · Full text

, , +16

Fc-γR-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2

Samantha Mackin, Pritesh Desai, Bradley Whitener et al. · Nature Microbiology · 2023 · 120 citations · Full text

, , +13

1–5 of 20